Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells

Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the development of individualized treatments has been limited by the lack of individualized infection models. In this study, we used human induced pluripotent stem cell (hiPSC) to generate a functional liver organoid...

Full description

Bibliographic Details
Main Authors: Yun-Zhong Nie, Yun-Wen Zheng, Kei Miyakawa, Soichiro Murata, Ran-Ran Zhang, Keisuke Sekine, Yasuharu Ueno, Takanori Takebe, Takaji Wakita, Akihide Ryo, Hideki Taniguchi
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396418303001
id doaj-9fbe19a7a9ad4baeb5c9e965f22d7b12
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yun-Zhong Nie
Yun-Wen Zheng
Kei Miyakawa
Soichiro Murata
Ran-Ran Zhang
Keisuke Sekine
Yasuharu Ueno
Takanori Takebe
Takaji Wakita
Akihide Ryo
Hideki Taniguchi
spellingShingle Yun-Zhong Nie
Yun-Wen Zheng
Kei Miyakawa
Soichiro Murata
Ran-Ran Zhang
Keisuke Sekine
Yasuharu Ueno
Takanori Takebe
Takaji Wakita
Akihide Ryo
Hideki Taniguchi
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
EBioMedicine
author_facet Yun-Zhong Nie
Yun-Wen Zheng
Kei Miyakawa
Soichiro Murata
Ran-Ran Zhang
Keisuke Sekine
Yasuharu Ueno
Takanori Takebe
Takaji Wakita
Akihide Ryo
Hideki Taniguchi
author_sort Yun-Zhong Nie
title Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
title_short Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
title_full Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
title_fullStr Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
title_full_unstemmed Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
title_sort recapitulation of hepatitis b virus–host interactions in liver organoids from human induced pluripotent stem cells
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2018-09-01
description Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the development of individualized treatments has been limited by the lack of individualized infection models. In this study, we used human induced pluripotent stem cell (hiPSC) to generate a functional liver organoid (LO) that inherited the genetic background of the donor, and evaluated its application in modeling HBV infection and exploring virus–host interactions. To establish a functional hiPSC-LO, we cultured hiPSC-derived endodermal, mesenchymal, and endothelial cells with a chemically defined medium in a three-dimensional microwell culture system. Based on cell-cell interactions, these cells could organize themselves and gradually differentiate into a functional organoid, which exhibited stronger hepatic functions than hiPSC derived hepatic like cell (HLC). Moreover, the functional LO demonstrated more susceptibility to HBV infection than hiPSC-HLC, and could maintain HBV propagation and produce infectious virus for a prolonged duration. Furthermore, we found that virus infection could cause hepatic dysfunction of hiPSC-LOs, with down-regulation of hepatic gene expression, induced release of early acute liver failure markers, and altered hepatic ultrastructure. Therefore, our study demonstrated that HBV infection in hiPSC-LOs could recapitulate virus life cycle and virus induced hepatic dysfunction, suggesting that hiPSC-LOs may provide a promising individualized infection model for the development of individualized treatment for hepatitis. Keywords: Liver organoid, hiPSC, Hepatitis B virus, Virus-host interactions
url http://www.sciencedirect.com/science/article/pii/S2352396418303001
work_keys_str_mv AT yunzhongnie recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT yunwenzheng recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT keimiyakawa recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT soichiromurata recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT ranranzhang recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT keisukesekine recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT yasuharuueno recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT takanoritakebe recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT takajiwakita recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT akihideryo recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
AT hidekitaniguchi recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells
_version_ 1725148882928664576
spelling doaj-9fbe19a7a9ad4baeb5c9e965f22d7b122020-11-25T01:17:00ZengElsevierEBioMedicine2352-39642018-09-0135114123Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cellsYun-Zhong Nie0Yun-Wen Zheng1Kei Miyakawa2Soichiro Murata3Ran-Ran Zhang4Keisuke Sekine5Yasuharu Ueno6Takanori Takebe7Takaji Wakita8Akihide Ryo9Hideki Taniguchi10Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan; Department of Advanced Gastroenterological Surgical Science and Technology, University of Tsukuba, Tsukuba-shi, Ibaraki 305-8575, Japan; Research Center of Stem Cells and Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China,; Corresponding authors at: Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan,Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, 162-8640 Tokyo, JapanDepartment of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan,Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan; Advanced Medical Research Center, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan; Corresponding authors at: Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the development of individualized treatments has been limited by the lack of individualized infection models. In this study, we used human induced pluripotent stem cell (hiPSC) to generate a functional liver organoid (LO) that inherited the genetic background of the donor, and evaluated its application in modeling HBV infection and exploring virus–host interactions. To establish a functional hiPSC-LO, we cultured hiPSC-derived endodermal, mesenchymal, and endothelial cells with a chemically defined medium in a three-dimensional microwell culture system. Based on cell-cell interactions, these cells could organize themselves and gradually differentiate into a functional organoid, which exhibited stronger hepatic functions than hiPSC derived hepatic like cell (HLC). Moreover, the functional LO demonstrated more susceptibility to HBV infection than hiPSC-HLC, and could maintain HBV propagation and produce infectious virus for a prolonged duration. Furthermore, we found that virus infection could cause hepatic dysfunction of hiPSC-LOs, with down-regulation of hepatic gene expression, induced release of early acute liver failure markers, and altered hepatic ultrastructure. Therefore, our study demonstrated that HBV infection in hiPSC-LOs could recapitulate virus life cycle and virus induced hepatic dysfunction, suggesting that hiPSC-LOs may provide a promising individualized infection model for the development of individualized treatment for hepatitis. Keywords: Liver organoid, hiPSC, Hepatitis B virus, Virus-host interactionshttp://www.sciencedirect.com/science/article/pii/S2352396418303001